SCHEMBL7698767

SCHEMBL7698767

COc1ccc2[nH]c(C)c(CC(=O)O)c2c1Cc1cccc(Cl)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C2 P52895 1/20 0.46
ALDH1A1 P00352 3/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
LMNA P02545 1/20 0.44
PTGDR2 Q9Y5Y4 2/20 0.43
PTGDR Q13258 1/20 0.43
PDE3B Q13370 1/20 0.42
PDE3A Q14432 1/20 0.42
PLA2G2A P14555 2/20 0.41
MAPT P10636 4/20 0.41
KDM4E B2RXH2 4/20 0.41
GAA P10253 3/20 0.41
POLB P06746 2/20 0.41
ALOX5 P09917 2/20 0.40
PTGES O14684 1/20 0.40
CASP1 P29466 1/20 0.40
CASP7 P55210 1/20 0.40
TUBB4A P04350 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7693001 0.88 AKR1C2 (0.49) AKR1C2ALDH1A1MEN1KMT2APTGDR2
SCHEMBL7698410 0.88 AKR1C2 (0.46) AKR1C2ALDH1A1MEN1KMT2AMAPT
SCHEMBL6013487 0.87 AKR1C2 (0.46) AKR1C2ALDH1A1MEN1KMT2ALMNA
SCHEMBL7698626 0.82 GAA (0.49) AKR1C2ALDH1A1MEN1KMT2ALMNA
SCHEMBL7698648 0.81 AKR1C2 (0.45) AKR1C2ALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL7694013 0.81 AKR1C2 (0.46) AKR1C2ALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL7699710 0.81 AKR1C2 (0.46) AKR1C2ALDH1A1MEN1KMT2APTGDR2
SCHEMBL9017471 0.79 AKR1C2 (0.47) AKR1C2ALDH1A1MEN1KMT2AMAPT
SCHEMBL7692673 0.79 AKR1C2 (0.45) AKR1C2ALDH1A1MEN1KMT2APTGDR2
SCHEMBL5810898 0.79 PTGS1 (0.48) AKR1C2ALDH1A1MEN1KMT2APTGDR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002020478-A1 N-BENZYLINDOLE-3-ACETIC ACID DERIVATIVES FOR USE IN THE TREATMENT OF DRUG RESISTAN CANCER DUBLIN CITY UNIVERSITY (IE) 2002-03-14 WO disclosed